Ekblad U, Erkkola R
Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.
Ann Chir Gynaecol Suppl. 1987;202:23-5.
Forty-five women with an unfavourable cervix (cervical score less than 3) and an obstetric indication for delivery were given intracervical prostaglandin E2 (PGE2) gel 0.5 mg/3 g to prime the uterine cervix. Twenty-one women (47%) went into labour after PGE2 gel application only. In 13 women (29%) the cervical score sufficiently improved within 12 hours and labour was successfully induced with intravenous oxytocin. The rate of adverse effects was notably: there were two uterine ruptures, the rate of cesarean sections was 33%, hypertonic uterine contractility 25%, premature rupture of membranes 16%, and neonatal asphyxia 21%. In our experience, cervical ripening with PGE2 gel, although efficient, may also bring about complications, which appear partly iatrogenic. Therefore, a critical evaluation of indications and the risk/benefit ratio is required.
45名宫颈条件不佳(宫颈评分低于3分)且有产科指征需分娩的女性接受了宫颈内注射0.5毫克/3克的前列腺素E2(PGE2)凝胶以软化宫颈。仅在应用PGE2凝胶后,21名女性(47%)开始分娩。13名女性(29%)的宫颈评分在12小时内充分改善,随后通过静脉注射缩宫素成功引产。不良反应发生率显著:发生了2例子宫破裂,剖宫产率为33%,子宫收缩过强为25%,胎膜早破为16%,新生儿窒息为21%。根据我们的经验,尽管PGE2凝胶促宫颈成熟有效,但也可能引发并发症,部分并发症似乎是医源性的。因此,需要对适应症以及风险/效益比进行严格评估。